One of the listed companies, Navana Pharmaceuticals PLC discloses its financial reports for the third quarter, (January – March 24).
The company’s earnings per share (EPS) was Tk 1.00 paisa in Q3 of the current financial year (January – March 24). EPS was Tk 1.09 paisa during the same period last year. NAV per share was Tk. 42.11 as on March 31, 2024.
Share this
